Consistent with the increased HCC formation, the expression of markers involved in ECM‐related genes (COL1A1, COL1A2 and α‐SAM), tumorigenesis (Afp, Gpc3 and Ly6d) and inflammation (TNF‐α, IL‐6 and IL‐β) (Figure S1F–H, Supporting Information). The gene discussed is LY6D; the disease is hepatocellular carcinoma.